Abstract
To enhance the bioavailability of carborane as a potential pharmacophore for BNCT, we labeled the modified o-carborane with the near-infrared dye IR775 and encapsulated it using two types of Eudragit® (pH-sensitive and osmotic). Consequently, four separate fluorescent complexes containing carborane were acquired. To confirm the nido-carborane presence within these complexes, the distinct peak at 2510 cm−1 was detected using infrared spectroscopy as a first step. The photophysical properties were observed in phosphate buffer with different pH. The UV and fluorescence spectra of the four fluorescent complexes were very similar, with the maximum absorption wavelengths centered in the range of 773–789 nm and the emission wavelengths centered in the range of 796–811 nm. Subsequently, a stable and releasing complex L100-C-IR775 was screened through zeta potential testing and simulated release experiments in the gastrointestinal environment, and spherical shape was observed by transmission electron microscopy. AFM imaging showed a relatively smooth surface with a uniform distribution of protrusions. The L100-C-IR775 was then applied to tumor cell imaging, and it was observed that it could enter into three kinds of tumor cells, A549, HCT116 and HeLa, and distribute around the nucleus. Finally, it was shown by a cell proliferation toxicity assay (CCK8) that the compound inhibited HeLa and PC-3 cells by 50 and 51% at concentrations up to 10 µg/mL. In conclusion, the carborane fluorescent complexes prepared in this paper have good biocompatibility and demonstrate toxicity toward tumor cell proliferation. Furthermore, they have the potential to serve as a carbon borane anti-tumor prodrug.
Graphical abstract
An acrylic encapsulated ionic polymer IR775@nido-carborane simulates release in the gastrointestinal environment, tumor cells imaging, and schematics of therapeutic mechanisms.
Similar content being viewed by others
References
Q. Dai, Q. Yang, X. Bao, J. Chen, M. Han, Q. Wei, The development of boron analysis and imaging in boron neutron capture therapy (BNCT). Mol. Pharm. 19(2), 363–377 (2022)
M. Suzuki, Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era. Int. J. Clin. Oncol. 25(1), 43–50 (2020)
P. Coghi, J. Li, N.S. Hosmane, Y. Zhu, Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment. Med. Res. Rev. 43(5), 1809–1830 (2023)
T. D. Malouff, D.S. Seneviratne, D.K. Ebner, W.C. Stross, M.R. Waddle, D.M. Trifiletti, S. Krishnan, Boron neutron capture therapy: a review of clinical applications. Front. Oncol. 11 (2021)
J. Chen, Q. Dai, Q. Yang, X. Bao, Y. Zhou, H. Zhong, L. Wu, T. Wang, Z. Zhang, Y. Lu et al., Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma. J. Nanobiotechnol. 20(1), 102 (2022)
I. Kato, K. Ono, Y. Sakurai, M. Ohmae, A. Maruhashi, Y. Imahori, M. Kirihata, M. Nakazawa, Y. Yura, Effectiveness of BNCT for recurrent head and neck malignancies. Appl. Radiat. Isot. 61(5), 1069–1073 (2004)
H. Fukuda, Boron neutron capture therapy (BNCT) for cutaneous malignant melanoma using B-10-p-boronophenylalanine (BPA) with special reference to the radiobiological basis and clinical results. Cells 10(11), 2881 (2021)
R. Nunez, M. Tarres, A. Ferrer-Ugalde, F.F. de Biani, F. Teixidor, Electrochemistry and photoluminescence of icosahedral carboranes, boranes, metallacarboranes, and their derivatives. Chem. Rev. 116(23), 14307–14378 (2016)
X. Wu, J. Guo, J. Zhao, Y. Che, D. Jia, Y. Chen, Multifunctional luminescent molecules of o-carborane–pyrene dyad/triad: flexible synthesis and study of the photophysical properties. Dyes Pigments 154, 44–51 (2018)
F. Ali, N.S. Hosmane, Y. Zhu, Boron chemistry for medical applications. Molecules 25(4), 828 (2020)
M. Gozzi, B. Schwarze, E. Hey-Hawkins, Preparing (metalla)carboranes for nanomedicine. ChemMedChem 16(10), 1533–1565 (2021)
Y. Duo, Z. Xie, L. Wang, N.M. Abbasi, T. Yang, Z. Li, G. Hu, H. Zhang, Borophene-based biomedical applications: status and future challenges. Coord. Chem. Rev. 427, 213549 (2021)
Y. Sha, Z. Zhou, M. Zhu, Z. Luo, E. Xu, X. Li, H. Yan, The mechanochemistry of carboranes. Angew. Chem. Int. Ed. 61(25), e202203169 (2022)
J. Wang, L. Chen, J. Ye, Z. Li, H. Jiang, H. Yan, M.Y. Stogniy, I.B. Sivaev, V.I. Bregadze, X. Wang, Carborane derivative conjugated with gold nanoclusters for targeted cancer cell imaging. Biomacromol 18(5), 1466–1472 (2017)
Y. Chen, F. Du, L. Tang, J. Xu, Y. Zhao, X. Wu, M. Li, J. Shen, Q. Wen, C.H. Cho et al., Carboranes as unique pharmacophores in antitumor medicinal chemistry. Mol. Ther.-Oncol. 24, 400–416 (2022)
A. Marfavi, P. Kavianpour, L.M. Rendina, Carboranes in drug discovery, chemical biology and molecular imaging. Nat. Rev. Chem. 6(7), 486–504 (2022)
R. Conway-Kenny, A. Ferrer-Ugalde, O. Careta, X. Cui, J. Zhao, C. Nogues, R. Nunez, J. Cabrera-Gonzalez, S.M. Draper, Ru(II) and Ir(III) phenanthroline-based photosensitisers bearing o-carborane: PDT agents with boron carriers for potential BNCT. Biomater. Sci. 9(16), 5691–5702 (2021)
Y. Wang, Y. Xu, J. Yang, X. Qiu, N. Li, Y. Zhu, L. Yan, W. Li, X. Huang, K. Liang et al., Carborane based mesoporous nanoparticles as a potential agent for BNCT. Mater. Chem. Front. 5(6), 2771–2776 (2021)
Y. Chen, L. Li, W. Chen, H. Chen, J. Yin, Near-infrared small molecular fluorescent dyes for photothermal therapy. Chin. Chem. Lett. 30(7), 1353–1360 (2019)
J. Jiao, J. Zhang, F. Yang, W. Song, D. Han, W. Wen, W. Qin, Quicker, deeper and stronger imaging: a review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages. Eur. J. Pharm. Biopharm. 152, 123–143 (2020)
D.-H. Li, C.L. Schreiber, B.D. Smith, Sterically shielded heptamethine cyanine dyes for bioconjugation and high performance near-infrared fluorescence imaging. Angew. Chem. Int. Ed. 59(29), 12154–12161 (2020)
M. Strobl, A. Walcher, T. Mayr, I. Klimant, S.M. Borisov, Trace ammonia sensors based on fluorescent near-infrared emitting aza-BODIPY dyes. Anal. Chem. 89(5), 2859–2865 (2017)
Y.Q. Sun, J. Liu, X. Lv, Y. Liu, Y. Zhao, P.D.W. Guo, Rhodaminderivate als Nahinfrarotfarbstoffe und ihre Anwendung in Fluoreszenzsonden. Angew. Chem. 124(31), 7752–7754 (2012)
G. Renno, F. Cardano, V. Ilieva, G. Viscardi, A. Fin, Near-infrared squaraine dyes as bright fluorescent probes: a structure-activity photophysical investigation in liposomes. Eur. J. Org. Chem. 2022(37), e202200833 (2022)
A. Barbieri, E. Bandini, F. Monti, V.K. Praveen, N. Armaroli, The rise of near-infrared emitters: organic dyes, porphyrinoids, and transition metal complexes. Top. Curr. Chem. 374(4), 47 (2016)
C. Sun, W. Du, B. Wang, B. Dong, B. Wang, Research progress of near-infrared fluorescence probes based on indole heptamethine cyanine dyes in vivo and in vitro. BMC Chem. 14(1), 21 (2020)
R. Huebner, V. Benkert, X. Cheng, B. Waengler, R. Kraemer, C. Waengler, Probing two PESIN-indocyanine-dye-conjugates: significance of the used fluorophore. J. Mater. Chem. B 8(6), 1302–1309 (2020)
G. Yeroslavsky, M. Umezawa, K. Okubo, K. Nigoghossian, D. Thi Kim Dung, K. Miyata, M. Kamimura, K. Soga, Stabilization of indocyanine green dye in polymeric micelles for NIR-II fluorescence imaging and cancer treatment. Biomater. Sci. 8(8), 2245–2254 (2020)
S. Thakral, N.K. Thakral, D.K. Majumdar, Eudragit (R): a technology evaluation. Expert Opin. Drug Deliv. 10(1), 131–149 (2013)
P. Franco, I. De Marco, Eudragit: a novel carrier for controlled drug delivery in supercritical antisolvent coprecipitation. Polymers 12(1), 234 (2020)
A. Nikam, P.R. Sahoo, S. Musale, R.R. Pagar, A.C. Paiva-Santos, P.S. Giram, A systematic overview of Eudragit((R)) based copolymer for Smart Healthcare. Pharmaceutics 15(2), 587 (2023)
P.-C. Wu, Y.-B. Huang, C.-H. Sung, R.-J. Wang, Y.-H. Tsai, The effect of Eudragit and enteric polymer composite on the release of Nicardipine. J. Food Drug Anal. 14(4), 334–339 (2006)
S.K. Jain, A.K. Jain, K. Rajpoot, Expedition of Eudragit(R) polymers in the development of novel drug delivery systems. Curr. Drug Deliv. 17(6), 448–469 (2020)
D.A. Real, A. Gagliano, N. Sonsini, G. Wicky, L. Orzan, D. Leonardi, C. Salomon, Design and optimization of pH-sensitive Eudragit nanoparticles for improved oral delivery of triclabendazole. Int. J. Pharm. 617, 121594 (2022)
A. Martin-Illana, R. Cazorla-Luna, F. Notario-Perez, J. Rubio, R. Ruiz-Caro, A. Tamayo, M.D. Veiga, Eudragit(R) L100/chitosan composite thin bilayer films for intravaginal pH-responsive release of Tenofovir. Int. J. Pharm. 616, 121554 (2022)
Y.B.G. Patriota, I.E.S. Arruda, A.C.D.J. Oliveira, T.C. de Oliveira, E.D.L.V. Silva, L.L. Chaves, F.D.O.S. Ribeiro, D.A. da Silva, M.F.D.L.R. Soares, J.L. Soares-Sobrinho, Synthesis of Eudragit(R) L100-coated chitosan-based nanoparticles for oral enoxaparin delivery. Int. J. Biol. Macromol. 193, 450–456 (2021)
J. Yin, C. Xiang, X. Song, Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability. Int. J. Pharm. 510(1), 203–209 (2016)
E. Marti Coma-Cros, A. Biosca, E. Lantero, M.L. Manca, C. Caddeo, L. Gutierrez, M. Ramirez, L. Neves Borgheti-Cardoso, M. Manconi, X. Fernandez-Busquets, Antimalarial activity of orally administered curcumin incorporated in Eudragit((R))-containing liposomes. Int. J. Mol. Sci. 19(5), 1361 (2018)
Y. Zhu, J. Yu, G. Zhou, Z. Gu, M. Adu-Frimpong, W. Deng, J. Yu, X. Xu, Piperine fast disintegrating tablets comprising sustained-release matrix pellets with enhanced bioavailability: formulation, in vitro and in vivo evaluation. Pharm. Dev. Technol. 25(5), 617–624 (2020)
C. Sun, W. Li, P. Ma, Y. Li, Y. Zhu, H. Zhang, M. Adu-Frimpong, W. Deng, J. Yu, X. Xu, Development of TPGS/F127/F68 mixed polymeric micelles: enhanced oral bioavailability and hepatoprotection of syringic acid against carbon tetrachloride-induced hepatotoxicity. Food Chem. Toxicol. 137, 111126 (2020)
A. Pitto-Barry, Polymers and boron neutron capture therapy (BNCT): a potent combination. Polym. Chem. 12(14), 2035–2044 (2021)
Z. Ruan, L. Liu, L. Fu, T. Xing, L. Yan, NIR bioimaging-guided carborane containing macromolecular agent for BNCT. J. Controll. Release 259, E190–E190 (2017)
H. Ouyang, Z. Wang, L. Huang, J. Hu, X. Ma, X. Feng, G. Jin, A simple and efficient visualization of Rhodamine B-nido-carborane fluorescent labeling for tumor cell imaging. J. Iran. Chem. Soc. 20, 2507–2516 (2023)
C. Wuerth, M. Grabolle, J. Pauli, M. Spieles, U. Resch-Genger, Relative and absolute determination of fluorescence quantum yields of transparent samples. Nat. Protoc. 8(8), 1535–1550 (2013)
Acknowledgements
This study was supported financially by the scientific research foundation of Jiangsu University (Grant no. 5501290005).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, S., Liu, Y., Zhou, M. et al. Based on Eudragit® encapsulated ionic polymer IR775@nido-carborane strategy: release, bioactivity and tumor cell imaging studies in simulated gastrointestinal environment. Macromol. Res. (2024). https://doi.org/10.1007/s13233-024-00250-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13233-024-00250-0